Claims for Patent: 9,486,428

Summary for Patent: 9,486,428

Title:	Treatment of intrahepatic cholestatic diseases
Abstract:	Treatment of intrahepatic cholestatic diseases by therapy with MBX-8025 or an MBX-8025 salt.
Inventor(s):	Boudes Pol, McWherter Charles A.
Assignee:	CymaBay Therapeutics, Inc.
Application Number:	US14663027
Patent Claims:	2. The method of where the (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)-phenoxy)propyl)thio)-2-methylphenoxy)acetic acid or a salt thereof is (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetic acid L-lysine dihydrate salt.3. The method of where the (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)-phenoxy)propyl)thio)-2-methylphenoxy)acetic acid or a salt thereof is administered orally.4. The method of where the daily dose of (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetic acid or a salt thereof claim 1 , when calculated as the free acid claim 1 , is 20-200 mg.5. The method of where the daily dose of (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetic acid or a salt thereof claim 3 , when calculated as the free acid claim 3 , is 50-100 mg.6. The method of where the (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)-phenoxy)propyl)thio)-2-methylphenoxy)acetic acid or a salt thereof is administered once/day.